LoadingLoadingLoadingThe latest filed buys.
Oct 23, 2026: insiders filed 8 open-market buys of $25K or more across 7 companies. Over the last 7 days: 44 buys across 32 companies.
| Insider | Company | Bought | Traded | Filed |
|---|---|---|---|---|
| Jerry Swank V | NXG3 insidersNXG NextGen Infrastructure Income Fund | $439K10,000 shares | ||
| Blake NelsonCFO & Treasurer | NXG3 insidersNXG NextGen Infrastructure Income Fund | $40K900 shares | ||
| Reuben E SloneDirector | MSMMsc Industrial Direct | $50K433 shares | ||
| Ramiro SanchezDirector | RAPP6 insidersRapport Therapeutics | $98K3,600 shares | ||
| Edilson CamaraDirector | CLFCleveland-Cliffs | $100K7,400 shares | ||
| Wenbin QiuChief Executive Officer | BZUNBaozun | $40K11,400 shares | ||
| Bin ZhaoChief Executive OfficerShares held by YY TZ LIMITED | APIAgora | $168K38,267 shares | ||
| Matthew Eugene WorleyDirector | CRAFXCascade Real Assets Fund | $431K41,909.531 shares | ||
| Peyton BoswellDirector | LIQTLiqtech International | $50K50,000 shares | ||
| Teresa Hillary ClarkeDirector | AMTAmerican Tower | $64K338.234 shares | ||
| Paul M SilvaDirectorShares held by Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016 | RAPP6 insidersRapport Therapeutics | $100K3,680 shares | ||
| Wendy B. YoungDirector | RAPP6 insidersRapport Therapeutics | $100K3,789 shares | ||
| Steven M PaulDirectorShares held by Paul Capital Strategy III Fund LLC | RAPP6 insidersRapport Therapeutics | $974K35,714 shares | ||
| John MaraganoreDirectorShares held by John M. Maraganore Revocable Trust | RAPP6 insidersRapport Therapeutics | $249K9,411 shares | ||
| John Yogi Spence | XFLTXAI Floating Rate & Alternative Income Trust | $34K2,000 shares | ||
| Assaf RanPresident and CEO, 10% owner | LOANManhattan Bridge Capital | $35K10,000 shares | ||
| David R EpsteinDirector | AGMBAgomAb Therapeutics | $89K10,000 shares | ||
| Orrin H Ingram IIDirector | FBKFB Financial | $1.5M29,081 shares | ||
| Ramin KamfarDirectorShares held by Shares purchased through an entity controlled by the Reporting Person | BPRE3 insidersBluerock Private Real Estate Fund | $3.3M271,555 shares | ||
| Troy A. IgnelziChief Financial Officer | RAPP6 insidersRapport Therapeutics | $144K5,500 shares | ||
| Joshua BradshawVice Chairman and President | CRFCornerstone Total Return Fund | $118K20,000 shares | ||
| Joshua BradshawVice Chairman and President | CLMCornerstone Strategic Investment Fund | $97K16,000 shares | ||
| Arne GrimmeDirector | NBISNebius Group N.V | $50K299 shares | ||
| Christoph Samuel ZieglerDirector | VRXAVeraxa Biotech | $33K30,000 shares | ||
| Byron L BostonCo-CEO & Chairman of the Board | DX3 insidersDynex Capital | $100K9,180 shares | ||
| Howard Timothy Eriksen10% owner | SKASSaker Aviation Services | $70K12,700 shares | ||
| David M VelazquezDirector | YORW2 insidersYork Water | $40K1,287.529 shares | ||
| Steven A Shaw10% ownerShares held by Rachel Lynn Shaw Trust | MHHMastech Digital | $30K4,700 shares | ||
| Chun Kai WangChief Executive Officer | OWLSObook Holdings | $52K12,192 shares | ||
| Kevin Tang10% owner | BOLDBoundless Bio | $350K149,474 shares | ||
| Smriti Laxman PopenoeCo-CEO and President | DX3 insidersDynex Capital | $157K12,000 shares | ||
| David C SimsCFO, CCO, Secretary, Treasurer | GRFEagle Capital Growth Fund | $109K10,787 shares | ||
| Todd Sunderland | NXG3 insidersNXG NextGen Infrastructure Income Fund | $47K1,000 shares | ||
| Jorey Chernett10% owner | XGNExagen | $104K14,000 shares | ||
| Arne GrimmeDirector | NBISNebius Group N.V | $25K148 shares | ||
| Evan Lockwood RachlinDirector | IAMIambic Therapeutics | $11.5M718,750 shares | ||
| Phil E MulacekDirector, 10% ownerShares held by Petroleum Independent & Exploration LLC | EPEmpire Petroleum | $313K97,981 shares | ||
| Robert NelsenDirector, 10% ownerShares held by ARCH Venture Fund XII, L.P. | CTY2 insidersCity Therapeutics | $3.1M170,000 shares | ||
| Ramin KamfarDirectorShares held by Shares purchased through an entity controlled by the Reporting Person | BPRE3 insidersBluerock Private Real Estate Fund | $2.4M194,228 shares | ||
| Lynn Sebastian PurcellDirector, 10% ownerShares held by OnePointTwo Capital Ventures II LLC | CNXUConexeu Sciences | $500K166,666 shares | ||
| Bin ZhaoChief Executive OfficerShares held by YY TZ LIMITED | APIAgora | $77K17,345 shares | ||
| Wes CumminsCEO; Chairman | APLD2 insidersApplied Digital | $1.0M55,803 shares | ||
| Jason Gechen ZhangPresident | APLD2 insidersApplied Digital | $5.7M300,000 shares | ||
| Barry H DashDirector | ELTPElite Pharmaceuticals | $26K100,000 shares |
Jerry Swank V
Traded Filed
Blake Nelson, CFO & Treasurer
Traded Filed
Reuben E Slone, Director
Traded Filed
Ramiro Sanchez, Director
Traded Filed
Edilson Camara, Director
Traded Filed
Wenbin Qiu, Chief Executive Officer
Traded Filed
Bin Zhao, Chief Executive Officer
Shares held by YY TZ LIMITED
Traded Filed
Matthew Eugene Worley, Director
Traded Filed
Peyton Boswell, Director
Traded Filed
Teresa Hillary Clarke, Director
Traded Filed
Paul M Silva, Director
Shares held by Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016
Traded Filed
Wendy B. Young, Director
Traded Filed
Steven M Paul, Director
Shares held by Paul Capital Strategy III Fund LLC
Traded Filed
John Maraganore, Director
Shares held by John M. Maraganore Revocable Trust
Traded Filed
John Yogi Spence
Traded Filed
Assaf Ran, President and CEO, 10% owner
Traded Filed
David R Epstein, Director
Traded Filed
Orrin H Ingram II, Director
Traded Filed
Ramin Kamfar, Director
Shares held by Shares purchased through an entity controlled by the Reporting Person
Traded Filed
Troy A. Ignelzi, Chief Financial Officer
Traded Filed
Joshua Bradshaw, Vice Chairman and President
Traded Filed
Joshua Bradshaw, Vice Chairman and President
Traded Filed
Arne Grimme, Director
Traded Filed
Christoph Samuel Ziegler, Director
Traded Filed
Byron L Boston, Co-CEO & Chairman of the Board
Traded Filed
Howard Timothy Eriksen, 10% owner
Traded Filed
David M Velazquez, Director
Traded Filed
Steven A Shaw, 10% owner
Shares held by Rachel Lynn Shaw Trust
Traded Filed
Chun Kai Wang, Chief Executive Officer
Traded Filed
Kevin Tang, 10% owner
Traded Filed
Smriti Laxman Popenoe, Co-CEO and President
Traded Filed
David C Sims, CFO, CCO, Secretary, Treasurer
Traded Filed
Todd Sunderland
Traded Filed
Jorey Chernett, 10% owner
Traded Filed
Arne Grimme, Director
Traded Filed
Evan Lockwood Rachlin, Director
Traded Filed
Phil E Mulacek, Director, 10% owner
Shares held by Petroleum Independent & Exploration LLC
Traded Filed
Robert Nelsen, Director, 10% owner
Shares held by ARCH Venture Fund XII, L.P.
Traded Filed
Ramin Kamfar, Director
Shares held by Shares purchased through an entity controlled by the Reporting Person
Traded Filed
Lynn Sebastian Purcell, Director, 10% owner
Shares held by OnePointTwo Capital Ventures II LLC
Traded Filed
Bin Zhao, Chief Executive Officer
Shares held by YY TZ LIMITED
Traded Filed
Wes Cummins, CEO; Chairman
Traded Filed
Jason Gechen Zhang, President
Traded Filed
Barry H Dash, Director
Traded Filed
Reported purchases by people of $25K or more, not recommendations.
| Insider | Company | Bought | Traded | Filed |
|---|---|---|---|---|
| Wes CumminsCEO; Chairman | APLD2 insidersApplied Digital | $1.0M55,803 shares | ||
| Bin ZhaoChief Executive OfficerShares held by YY TZ LIMITED | APIAgora | $168K38,267 shares | ||
| Smriti Laxman PopenoeCo-CEO and President | DX3 insidersDynex Capital | $157K12,000 shares | ||
| Troy A. IgnelziChief Financial Officer | RAPP6 insidersRapport Therapeutics | $144K5,500 shares | ||
| Joshua BradshawVice Chairman and President | CRFCornerstone Total Return Fund | $118K20,000 shares | ||
| David C SimsCFO, CCO, Secretary, Treasurer | GRFEagle Capital Growth Fund | $109K10,787 shares | ||
| Byron L BostonCo-CEO & Chairman of the Board | DX3 insidersDynex Capital | $100K9,180 shares | ||
| Joshua BradshawVice Chairman and President | CLMCornerstone Strategic Investment Fund | $97K16,000 shares |
Wes Cummins, CEO; Chairman
Traded Filed
Bin Zhao, Chief Executive Officer
Shares held by YY TZ LIMITED
Traded Filed
Smriti Laxman Popenoe, Co-CEO and President
Traded Filed
Troy A. Ignelzi, Chief Financial Officer
Traded Filed
Joshua Bradshaw, Vice Chairman and President
Traded Filed
David C Sims, CFO, CCO, Secretary, Treasurer
Traded Filed
Byron L Boston, Co-CEO & Chairman of the Board
Traded Filed
Joshua Bradshaw, Vice Chairman and President
Traded Filed
The newest filing day in our data is shown above in UTC, which can be yesterday or earlier on a weekend. The list covers the last 7 days of filings, not trades made today. It includes reported open-market purchases by people of at least $25,000 and excludes grants and option exercises. Each row links its trade date, filing date and original Form 4.